Cargando…
Impact of COVID-19 pandemic on migraine management in the United States: insights from migraine tracking app users
BACKGROUND: The nature of COVID-19 pandemic measures has altered the clinical management of migraine, and has also created barriers to evaluate the impact of such measures of migraine patients. Using the Migraine Buddy smartphone application, we assessed the impact of the COVID-19 pandemic on migrai...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426333/ https://www.ncbi.nlm.nih.gov/pubmed/34503456 http://dx.doi.org/10.1186/s12883-021-02378-3 |
_version_ | 1783750021737349120 |
---|---|
author | Kato, Yuji Poh, Weijie Horvath, Zsolt Cadiou, François Shimazu, Tomokazu Maruki, Yuichi |
author_facet | Kato, Yuji Poh, Weijie Horvath, Zsolt Cadiou, François Shimazu, Tomokazu Maruki, Yuichi |
author_sort | Kato, Yuji |
collection | PubMed |
description | BACKGROUND: The nature of COVID-19 pandemic measures has altered the clinical management of migraine, and has also created barriers to evaluate the impact of such measures of migraine patients. Using the Migraine Buddy smartphone application, we assessed the impact of the COVID-19 pandemic on migraine in users residing in the United States. METHODS: Migraine Buddy is a smartphone application by individuals to record their migraine headache episodes, characteristics, and coping mechanisms. For this study, anonymized self-reported data from 163,176 adult Migraine Buddy users in the United States between January 2020 and May 2020, were analyzed for migraines associated with stress. A stress-related migraine is defined as one in which stress or anxiety was reported as a trigger or symptom. A questionnaire on the impact of COVID-19 on migraine and its management was also completed by 923 users from the United States in the app between April 2020 and May 2020. RESULTS: 88% of the Migraine Buddy database extract and 84% of the respondents are female, with a mean age of 36.2 years. The proportion of stress-related migraine attacks peaked at 53% on March 21 to 23, although the number of migraine attacks decreased. This followed the declaration of the COVID-19 national emergency on March 13 and a spike in the number of COVID-19 cases in the United States. Questionnaire respondents felt that the following added more stress: social isolation (22.6%), information overdose (21.2%), access to essentials (food, medication, etc.) (18.7%), and financial concerns (17.8%). To help manage migraine during COVID-19, respondents suggested stress and diet coaching programs and resources (medical articles, etc.) (34.0%), having the option for home delivery of medication (30.6%) and tele-consulting (25.5%). CONCLUSION: Here, we report the change in the proportion of self-reported stress-related migraine in relation to evolution of the COVID-19 pandemic, as well as its impact of migraine management. Our data will help increase the understanding of patients’ needs and help with planning and execution of mitigating strategies. |
format | Online Article Text |
id | pubmed-8426333 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-84263332021-09-09 Impact of COVID-19 pandemic on migraine management in the United States: insights from migraine tracking app users Kato, Yuji Poh, Weijie Horvath, Zsolt Cadiou, François Shimazu, Tomokazu Maruki, Yuichi BMC Neurol Research Article BACKGROUND: The nature of COVID-19 pandemic measures has altered the clinical management of migraine, and has also created barriers to evaluate the impact of such measures of migraine patients. Using the Migraine Buddy smartphone application, we assessed the impact of the COVID-19 pandemic on migraine in users residing in the United States. METHODS: Migraine Buddy is a smartphone application by individuals to record their migraine headache episodes, characteristics, and coping mechanisms. For this study, anonymized self-reported data from 163,176 adult Migraine Buddy users in the United States between January 2020 and May 2020, were analyzed for migraines associated with stress. A stress-related migraine is defined as one in which stress or anxiety was reported as a trigger or symptom. A questionnaire on the impact of COVID-19 on migraine and its management was also completed by 923 users from the United States in the app between April 2020 and May 2020. RESULTS: 88% of the Migraine Buddy database extract and 84% of the respondents are female, with a mean age of 36.2 years. The proportion of stress-related migraine attacks peaked at 53% on March 21 to 23, although the number of migraine attacks decreased. This followed the declaration of the COVID-19 national emergency on March 13 and a spike in the number of COVID-19 cases in the United States. Questionnaire respondents felt that the following added more stress: social isolation (22.6%), information overdose (21.2%), access to essentials (food, medication, etc.) (18.7%), and financial concerns (17.8%). To help manage migraine during COVID-19, respondents suggested stress and diet coaching programs and resources (medical articles, etc.) (34.0%), having the option for home delivery of medication (30.6%) and tele-consulting (25.5%). CONCLUSION: Here, we report the change in the proportion of self-reported stress-related migraine in relation to evolution of the COVID-19 pandemic, as well as its impact of migraine management. Our data will help increase the understanding of patients’ needs and help with planning and execution of mitigating strategies. BioMed Central 2021-09-09 /pmc/articles/PMC8426333/ /pubmed/34503456 http://dx.doi.org/10.1186/s12883-021-02378-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Kato, Yuji Poh, Weijie Horvath, Zsolt Cadiou, François Shimazu, Tomokazu Maruki, Yuichi Impact of COVID-19 pandemic on migraine management in the United States: insights from migraine tracking app users |
title | Impact of COVID-19 pandemic on migraine management in the United States: insights from migraine tracking app users |
title_full | Impact of COVID-19 pandemic on migraine management in the United States: insights from migraine tracking app users |
title_fullStr | Impact of COVID-19 pandemic on migraine management in the United States: insights from migraine tracking app users |
title_full_unstemmed | Impact of COVID-19 pandemic on migraine management in the United States: insights from migraine tracking app users |
title_short | Impact of COVID-19 pandemic on migraine management in the United States: insights from migraine tracking app users |
title_sort | impact of covid-19 pandemic on migraine management in the united states: insights from migraine tracking app users |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426333/ https://www.ncbi.nlm.nih.gov/pubmed/34503456 http://dx.doi.org/10.1186/s12883-021-02378-3 |
work_keys_str_mv | AT katoyuji impactofcovid19pandemiconmigrainemanagementintheunitedstatesinsightsfrommigrainetrackingappusers AT pohweijie impactofcovid19pandemiconmigrainemanagementintheunitedstatesinsightsfrommigrainetrackingappusers AT horvathzsolt impactofcovid19pandemiconmigrainemanagementintheunitedstatesinsightsfrommigrainetrackingappusers AT cadioufrancois impactofcovid19pandemiconmigrainemanagementintheunitedstatesinsightsfrommigrainetrackingappusers AT shimazutomokazu impactofcovid19pandemiconmigrainemanagementintheunitedstatesinsightsfrommigrainetrackingappusers AT marukiyuichi impactofcovid19pandemiconmigrainemanagementintheunitedstatesinsightsfrommigrainetrackingappusers |